Bharathi V, Bajpai A, Parappuram I, Patel B. Elevated constitutive expression of Hsp40 chaperone Sis1 reduces TDP-43 aggregation-induced oxidative stress in Ire1 pathway dependent-manner in yeast TDP-43 proteinopathy model of amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2022;595:28-34 pubmed publisher

Park S, Park S, Watanabe N, Hashimoto T, Iwatsubo T, Shelkovnikova T, et al. Calcium-responsive transactivator (CREST) toxicity is rescued by loss of PBP1/ATXN2 function in a novel yeast proteinopathy model and in transgenic flies. PLoS Genet. 2019;15:e1008308 pubmed publisher

Prasad A, Raju G, Sivalingam V, Girdhar A, Verma M, Vats A, et al. An acridine derivative, [4,5-bis{(N-carboxy methyl imidazolium)methyl}acridine] dibromide, shows anti-TDP-43 aggregation effect in ALS disease models. Sci Rep. 2016;6:39490 pubmed publisher

Bharathi V, Girdhar A, Prasad A, Verma M, Taneja V, Patel B. Use of ade1 and ade2 mutations for development of a versatile red/white colour assay of amyloid-induced oxidative stress in saccharomyces cerevisiae. Yeast. 2016;33:607-620 pubmed publisher

Johnson B, Snead D, Lee J, McCaffery J, Shorter J, Gitler A. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem. 2009;284:20329-39 pubmed publisher